Jun 23, 2024, 18:54
Impact of Hormone Receptor Status in Young BRCA Carriers
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X: .
“Impact of Hormone Receptor Status and Tumor Subtypes of Breast Cancer in Young BRCA Carriers – Annals of Oncology
•In young BRCA carriers, hormone receptor status did not appear to be a strong positive prognostic factor.
• Patients with luminal A-like disease seem to have the worst DFS compared to all the other subtypes.
• Personalized treatment, surveillance, and prevention strategies based on disease biology are recommended in young BRCA carriers.”
Source: Elisabetta Bonzano/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 15, 2024, 07:05
Nov 15, 2024, 07:03
Nov 15, 2024, 06:33
Nov 15, 2024, 05:57
Nov 14, 2024, 17:57